People with epilepsy in China are less likely to have a COVID-19 vaccine than their healthy counterparts

Takeaway

  • In China, COVID-19 vaccine uptake in people with epilepsy is much lower than in healthy controls, despite the lack of association with adverse effects or loss of seizure control.

Why this matters

  • High global uptake of COVID-19 vaccines is needed to recover from the ongoing pandemic; however, with concerns raised about the safety and efficacy of the COVID-19 vaccines in people with epilepsy, uptake in this population has been slow.

  • This important real-world study in people with epilepsy shows that despite vaccines being well tolerated and not linked to worsening seizure control, uptake is much lower than in their healthy counterparts. The findings suggest that education focused on increasing the vaccine coverage in people with epilepsy is needed.